# When will Anduril officially announce an IPO?

Anduril

Updated: April 17, 2026

Category: Companies

Tags: IPOs

HTML: /markets/companies/ipos/when-will-anduril-officially-announce-an-ipo/

## Short Answer

**Key takeaway.** The **model** sees potential mispricing: Anduril announcing an IPO before May 1, 2027 at **10.7%** **model** vs **21.0%** **market**, suggesting that a large private funding round is delaying a public offering.

## Key Claims (January 2026)

**- - Anduril is pursuing a large private funding round at higher valuation.** - Private funding is a key factor delaying Anduril's public offering.
- Anduril has not initiated formal lead underwriter selection for an IPO.
- Analyst predictions suggest low IPO likelihood for Anduril before 2027.
- Investor fund lifecycles are unconfirmed, hindering liquidity event pressure assessment.

### Why This Matters (GEO)

- AI agents extract claims, not arguments.
- Improves citation probability in summaries and answer cards.
- Enables fact stitching across multiple sources.

## Executive Verdict

**Model's 2% probability vs.** 4c **market** implies a 25x payout, as private funding discussions delay an IPO.

### Who Wins and Why

| Outcome | Market | Model | Why |
| --- | --- | --- | --- |
| Before May 1, 2026 | 4.0% | 2.0% | Market higher by 2.0pp |
| Before Jun 1, 2026 | 3.0% | 2.0% | Market higher by 1.0pp |
| Before Jul 1, 2026 | 5.0% | 2.5% | Market higher by 2.5pp |

## Model vs Market

| Outcome | Market Probability | Octagon Model Probability |
| --- | --- | --- |
| Before May 1, 2026 | 4.0% | 2.0% |
| Before Jun 1, 2026 | 3.0% | 2.0% |
| Before Jul 1, 2026 | 5.0% | 2.5% |
| Before Aug 1, 2026 | 5.0% | 2.5% |
| Before Sep 1, 2026 | 7.0% | 3.5% |
| Before Oct 1, 2026 | 6.0% | 3.5% |
| Before Nov 1, 2026 | 7.0% | 3.5% |
| Before Dec 1, 2026 | 11.0% | 5.5% |
| Before Jan 1, 2027 | 13.0% | 6.5% |
| Before Feb 1, 2027 | 12.0% | 6.5% |
| Before Mar 1, 2027 | 9.0% | 6.5% |
| Before Apr 1, 2027 | 18.0% | 9.1% |
| Before May 1, 2027 | 21.0% | 10.7% |
| Before Jun 1, 2027 | 18.0% | 10.7% |

- Expiration: June 1, 2027

## Market Behavior & Price Dynamics

Based on the provided chart data, the market for "When will Anduril officially announce an IPO?" has exhibited a complete lack of price movement. The probability has remained static at 4.0% from the market's inception to the present day. The trend is perfectly sideways, with no price spikes, drops, or any volatility. This indicates that the market's initial assessment has not been challenged or changed over the course of 46 data points.

The trading volume is exceptionally low, with a total of only 16 contracts traded throughout the market's history. The sample data points all show zero volume, reinforcing the observation of minimal trading activity. This low volume suggests a very illiquid market with little trader conviction or participation. As there have been no significant price movements, there are no market-moving events to analyze from the provided context.

The 4.0% level has acted as the absolute support and resistance level, as the price has never deviated from this point. The market sentiment appears to be firmly fixed on a very low probability of an Anduril IPO announcement within the resolution period. The combination of a static price and negligible volume implies that no new information has been introduced to persuade the few participants to alter their assessment of the event's likelihood.

## Contract Snapshot

The market resolves to "Yes" if Anduril confirms an IPO before June 1, 2027, based on reports from specified major news outlets. An IPO is confirmed if the SEC declares the company's Form S-1 effective, the IPO is priced, or a securities exchange assigns a ticker. If an IPO is not confirmed by May 31, 2027, at 11:59pm EDT, the market resolves to "No"; however, the market will close early if a "Yes" event occurs before this deadline.

## Market Discussion

Limited public discussion available for this market.

## Market Data

| Contract | Yes Bid | Yes Ask | Last Price | Volume | Open Interest |
| --- | --- | --- | --- | --- | --- |
| Before Aug 1, 2026 | 0% | 5% | 5% | $1,280 | $551 |
| Before Dec 1, 2026 | 3% | 12% | 11% | $3,522.58 | $1,497.58 |
| Before Jul 1, 2026 | 0% | 5% | 5% | $1,149 | $680 |
| Before Jun 1, 2026 | 0% | 3% | 3% | $3,785 | $3,112 |
| Before May 1, 2026 | 0% | 1% | 4% | $1,720 | $1,486 |
| Before Nov 1, 2026 | 0% | 7% | 7% | $1,275.12 | $867.12 |
| Before Oct 1, 2026 | 0% | 6% | 6% | $702 | $221 |
| Before Sep 1, 2026 | 0% | 6% | 7% | $564 | $250 |
| Before Apr 1, 2027 | 10% | 18% | 18% | $4,414.5 | $1,225.97 |
| Before Feb 1, 2027 | 12% | 16% | 12% | $9,085.66 | $6,050.3 |
| Before Jan 1, 2027 | 3% | 13% | 13% | $5,124 | $2,466 |
| Before Jun 1, 2027 | 20% | 23% | 18% | $19,606.32 | $8,739.76 |
| Before Mar 1, 2027 | 8% | 15% | 9% | $3,548.76 | $2,532.38 |
| Before May 1, 2027 | 15% | 20% | 21% | $5,994.23 | $2,658.36 |

## What Are Anduril's Disclosed Financial Targets for a $12B+ IPO?

IPO Intention | Confirmed by CEO Palmer Luckey [[^]](https://cnbc.com/2025/06/10/anduril-palmer-luckey-ipo.html) |
Reported 2023 Revenue | Approximately $600 million [[^]](https://www.cbinsights.com/company/anduril/financials) |
Projected 2024 Revenue | Around $1 billion [[^]](https://www.cbinsights.com/company/anduril/financials) or $1.1 billion [[^]](https://gitnux.org/anduril-statistics/) |

**Anduril's CEO confirms IPO plans amidst significant valuation discrepancies**

Anduril's CEO confirms IPO plans amidst significant valuation discrepancies. Palmer Luckey has publicly stated that the company "definitely" intends to go public [[^]](https://cnbc.com/2025/06/10/anduril-palmer-luckey-ipo.html). The company's valuation has been reported with considerable variation, ranging from **$10.1** billion in early 2023, which was based on approximately **$600** million in trailing twelve-month (TTM) revenue [[^]](https://sacra.com/research/anduril), to more recent estimations as high as **$28** billion [[^]](https://www.tradingcalendar.com/post/anduril-industries-ipo-valuation-soars-to-28b-here-s-what-investors-need-to-know) and **$30.5** billion [[^]](https://techmarketbriefs.com/pre-ipo/anduril/).

Anduril shows strong revenue growth with future projections. The company reported **$400** million in revenue during 2022, which subsequently increased to an estimated **$600** million in 2023 [[^]](https://www.cbinsights.com/company/anduril/financials). Projections for 2024 further estimate revenues to reach approximately **$1** billion [[^]](https://www.cbinsights.com/company/anduril/financials) or **$1.1** billion [[^]](https://gitnux.org/anduril-statistics/), with some forecasts suggesting a potential increase to **$2.2** billion by 2025 [[^]](https://gitnux.org/anduril-statistics/).

Specific board-established financial targets remain undisclosed for IPO justification. Despite the varying valuations and revenue figures, the available research does not disclose specific TTM revenue or free cash flow margin targets that Anduril's board has established as the minimum financial threshold to justify an IPO valuation exceeding **$12** billion.

## What is the Likelihood of Anduril IPO by Q4 2026?

IPO Probability Before 2027 | 21% (79% predicting against) [[^]](https://www.frenflow.com/polymarket/market/anduril-industries-ipo-before-2027) |
Company Valuation (June 2025) | $30.5 billion [[^]](https://techcrunch.com/2025/06/05/anduril-raises-2-5b-at-30-5b-valuation-led-by-founders-fund/), [[^]](https://www.cnbc.com/2025/06/05/anduril-valuation-founders-fund.html) |
Investor Fund Lifecycle Details | Not specified for Founders Fund or Valor Equity Partners [[^]](https://techcrunch.com/2025/06/05/anduril-raises-2-5b-at-30-5b-valuation-led-by-founders-fund/), [[^]](https://www.cnbc.com/2025/06/05/anduril-valuation-founders-fund.html), [[^]](https://www.employbl.com/companies/anduril-industries/funding-rounds), [[^]](https://acuitypartnersnyc.com/anduril-raises-1-48-billion-in-series-e-funding/), [[^]](https://www.foundersfund.com/) |

**Specific investor fund lifecycles remain unconfirmed, hindering liquidity event pressure assessment**

Specific investor fund lifecycles remain unconfirmed, hindering liquidity event pressure assessment. Founders Fund is a significant investor in Anduril, having led a **$2.5** billion funding round in June 2025 that valued the company at **$30.5** billion [[^]](https://techcrunch.com/2025/06/05/anduril-raises-2-5b-at-30-5b-valuation-led-by-founders-fund/), [[^]](https://www.cnbc.com/2025/06/05/anduril-valuation-founders-fund.html). While venture capital firms typically seek liquidity events within certain fund lifecycles to return capital to their limited partners, available sources do not provide specific fund lifecycle details for Founders Fund's investments in Anduril, nor do they detail Valor Equity Partners' involvement or fund lifecycles [[^]](https://techcrunch.com/2025/06/05/anduril-raises-2-5b-at-30-5b-valuation-led-by-founders-fund/), [[^]](https://www.cnbc.com/2025/06/05/anduril-valuation-founders-fund.html), [[^]](https://www.employbl.com/companies/anduril-industries/funding-rounds), [[^]](https://acuitypartnersnyc.com/anduril-raises-1-48-billion-in-series-e-funding/), [[^]](https://www.foundersfund.com/). This absence of specific data makes it challenging to directly link investor fund lifecycles to pressure for a liquidity event by Q4 2026.

**Market** predictions show low IPO **probability** before Q4 2026. Despite the potential for investor pressure, current **market** predictions suggest a low likelihood of an Anduril IPO occurring before Q4 2026 or 2027. One prediction **market** indicated only a **21%** **probability** of Anduril having an IPO before 2027, with **79%** predicting against it [[^]](https://www.frenflow.com/polymarket/**market**/anduril-industries-ipo-before-2027). Additionally, another source noted a "plummeting" IPO **probability** for Anduril, citing "investor reality checks" within a "mixed 2026 IPO landscape" [[^]](https://octagonai.co/news/anduril-s-ipo-**probability**-plummets-a-tech-giant-faces-investor-reality-checks-am-2026-03-06/). These **market** sentiments collectively indicate that a liquidity event, such as an IPO, is not strongly anticipated by the end of 2026.

## Is CCA Program Decision a Go/No-Go for Anduril's 2026 IPO?

Anduril IPO Plans | Confirmed by CEO Palmer Luckey, aiming for "trillion-dollar defense contracts" [[^]](https://www.benzinga.com/markets/ipos/25/06/45877601/anduril-ceo-palmer-luckey-confirms-ipo-plans-to-compete-for-trillion-dollar-defense-contracts-we-are) |
CCA Program Procurement | US Air Force plans nearly $1 billion for initial drone purchases by 2027 [[^]](https://www.airandspaceforces.com/air-force-nearly-1-billion-to-start-buying-ccas-2027/) |
Potential Anduril IPO Valuation | Around $30.5 billion (2026 analysis) [[^]](https://techmarketbriefs.com/pre-ipo/anduril/) |

**Anduril's CEO confirmed IPO plans, actively pursuing major defense contracts**

Anduril's CEO confirmed IPO plans, actively pursuing major defense contracts. Palmer Luckey, CEO of Anduril, has publicly stated the company's intention to file an Initial Public Offering (IPO), positioning itself to compete for substantial "trillion-dollar defense contracts" [[^]](https://www.benzinga.com/markets/ipos/25/06/45877601/anduril-ceo-palmer-luckey-confirms-ipo-plans-to-compete-for-trillion-dollar-defense-contracts-we-are). The company is an active participant in the U.S. Air Force's Collaborative Combat Aircraft (CCA) program, having been selected in April 2024 for the next development phase [[^]](https://breakingdefense.com/2024/04/air-force-picks-anduril-general-atomics-for-next-round-of-cca-work/). The Air Force expects to select the first autonomous fighter by the end of the current year and plans to allocate nearly **$1** billion to begin procuring CCA drones in 2027 [[^]](https://www.flightglobal.com/military-uavs/2026/02/us-air-force-confirms-selection-of-first-autonomous-fighter-coming-by-year-end/).

The CCA program's importance for Anduril is clear, yet a direct IPO link is not. While large defense contracts, such as the CCA program, are significant for Anduril's long-term financial health and growth, which would support a potential 2026 IPO with an estimated valuation of **$30.5** billion [[^]](https://techmarketbriefs.com/pre-ipo/anduril/), the available research does not contain an explicit statement from company insiders directly linking the outcome or timing of the U.S. Air Force's final decision on the CCA program as a determinant for the 2026 IPO filing. Reports indicate that delays in the CCA program were attributed to a push for a 'semi-autonomous' first flight, projected for September 2025 [[^]](https://www.defenseone.com/business/2025/09/anduril-blames-cca-delays-push-semi-autonomous-first-flight/408278/).

## What are Anduril's latest funding and IPO expectations?

New Funding Target | Up to $8 billion at over $60 billion valuation [[^]](https://www.mainsights.io/ma-news/anduril-industries-in-talks-for-up-to-8-billion-funding-round-at-over-60-billion-valuation) |
Previous Valuation | Approximately $30.5 billion [[^]](https://techmarketbriefs.com/pre-ipo/anduril/) |
IPO Delay Probability | 79% until at least 2027 [[^]](https://www.frenflow.com/polymarket/market/anduril-industries-ipo-before-2027) |

**Anduril Industries seeks significant private funding at an ambitious valuation**

Anduril Industries seeks significant private funding at an ambitious valuation. The company is reportedly in discussions to raise a new private funding round of up to **$8** billion, targeting a valuation exceeding **$60** billion [[^]](https://www.mainsights.io/ma-news/anduril-industries-in-talks-for-up-to-8-billion-funding-round-at-over-60-billion-valuation). One report also indicated a target of **$4** billion in funding aimed at doubling its valuation, which aligns with the aspiration for a **$60** billion range and would significantly increase the company's previous approximate valuation of **$30.5** billion [[^]](https://www.reuters.com/business/anduril-set-double-its-valuation-with-4-billion-funding-round-source-says-2026-03-03/).

Sovereign wealth funds are capable of supporting a delayed IPO. These funds are well-positioned to lead or substantially contribute to such large private funding rounds, demonstrating significant capacity for investments in private companies [[^]](https://www.sovereignmagazine.com/finance/sovereign-wealth-funds-have-become-the-worlds-most-powerful-venture-capitalists/). The availability of private capital is crucial for delaying a public offering. Prediction markets show a high **probability**, approximately **79%**, that Anduril's IPO will not occur before 2027 [[^]](https://www.frenflow.com/polymarket/**market**/anduril-industries-ipo-before-2027). This **market** sentiment suggests that sufficient private funding is either expected or available at a valuation attractive enough to postpone a public listing for several years [[^]](https://predictionpulse.io/**market**/polymarket/polymarket-anduril-ipo-before-2027).

## Has Anduril Started Underwriter Selection for Its IPO?

Lead Underwriter Selection | Not publicly announced [[^]](https://www.cnbc.com/2025/06/10/anduril-palmer-luckey-ipo.html) |
Anduril CFO | Babak Siavoshy (since January 2022) [[^]](https://ramp.com/blog/anduril-cfo-babak-siavoshy) |
CFO Public Market Experience | 13 years at Goldman Sachs (VP, investment banking) [[^]](https://ramp.com/blog/anduril-cfo-babak-siavoshy) |

**Anduril has not publicly announced lead underwriter selection process**

Anduril has not publicly announced lead underwriter selection process. The company has not initiated a formal 'bake-off' to select lead underwriters, such as Goldman Sachs or Morgan Stanley. This procedural step often precedes an S-1 filing. While available sources discuss Anduril's intent to go public and its valuation, they do not detail specific progress on the underwriter selection process [[^]](https://www.cnbc.com/2025/06/10/anduril-palmer-luckey-ipo.html).

Anduril has a permanent, experienced Chief Financial Officer. Babak Siavoshy has served as Anduril's permanent Chief Financial Officer since January 2022 [[^]](https://ramp.com/blog/anduril-cfo-babak-siavoshy). Mr. Siavoshy's background includes 13 years at Goldman Sachs, where he reached the position of Vice President in investment banking, providing him with extensive exposure to public companies, capital markets, and the IPO process [[^]](https://ramp.com/blog/anduril-cfo-babak-siavoshy). Prior to joining Anduril, he also served as CFO at two other companies [[^]](https://www.cfosecrets.io/p/oneonone-interview-series-babak-siavoshy-cfo-anduril).

## What Could Change the Odds

**Key takeaway.** Catalyst analysis unavailable.

## Key Dates & Catalysts

- **Expiration:** March 08, 2026
- **Closes:** June 01, 2027

## Decision-Flipping Events

- Catalyst analysis unavailable.

## Related Research Reports

- [When will Apple announce foldable iPhone?](/markets/companies/product-launches/when-will-apple-announce-foldable-iphone/)
- [Jamie Dimon leaves JPMorgan Chase?](/markets/companies/ceos/jamie-dimon-leaves-jpmorgan-chase/)
- [When will Tim Cook leave Apple?](/markets/companies/ceos/when-will-tim-cook-leave-apple/)
- [Will Paramount acquire Warner Bros?](/markets/companies/will-paramount-acquire-warner-bros/)

## Historical Resolutions

**Historical Resolutions:** 2 markets in this series

**Outcomes:** 0 resolved YES, 2 resolved NO

**Recent resolutions:**

- KXIPOANDURIL-26MAR01: NO (Mar 01, 2026)
- KXIPOANDURIL-26APR01: NO (Apr 01, 2026)

## Disclaimer

This content is for informational and educational purposes only and does not constitute financial, investment, legal, or trading advice.
Prediction markets involve risk of loss. Past performance does not guarantee future results.
We are not affiliated with Kalshi or any prediction market platform. Market data may be delayed or incomplete.

### Data Sources & Model Transparency

**Data Sources:** Octagon Deep Research aggregates information from multiple sources including news, filings, and market data.

**Freshness:** Analysis is generated periodically and may not reflect the latest developments. Verify critical information from primary sources.